OSR (NASDAQ:OSRH – Get Free Report) and Vine Hill Capital Investment (NASDAQ:VCIC – Get Free Report) are both small-cap manufacturing companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings.
Valuation & Earnings
This table compares OSR and Vine Hill Capital Investment”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| OSR | N/A | N/A | -$2.41 million | ($1.12) | -0.66 |
| Vine Hill Capital Investment | N/A | N/A | $2.28 million | $0.14 | 76.21 |
Risk and Volatility
OSR has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Vine Hill Capital Investment has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations and price targets for OSR and Vine Hill Capital Investment, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| OSR | 1 | 0 | 0 | 0 | 1.00 |
| Vine Hill Capital Investment | 1 | 0 | 0 | 0 | 1.00 |
Insider and Institutional Ownership
55.3% of OSR shares are owned by institutional investors. 60.6% of OSR shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares OSR and Vine Hill Capital Investment’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| OSR | N/A | -6.66% | -4.90% |
| Vine Hill Capital Investment | N/A | N/A | N/A |
Summary
Vine Hill Capital Investment beats OSR on 5 of the 8 factors compared between the two stocks.
About OSR
OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.
About Vine Hill Capital Investment
Vine Hill Capital Investment Corp. is a blank check company. It formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Vine Hill Capital Investment Corp. is based in Fort Lauderdale, Florida.
Receive News & Ratings for OSR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OSR and related companies with MarketBeat.com's FREE daily email newsletter.
